Featured Blog Post Image

Research at the New York Influenza Center of Excellence Continues with New NIH Grant

Researchers were awarded approximately $3 million from the National Institutes of Health to continue studying how our bodies respond to seasonal and pandemic flu viruses and vaccines. 

Drug May Blunt Neurological Damage Caused by Liver Failure

Individuals with impaired liver function are unable to remove ammonia – a by-product of normal cellular activity – from their bodies fast enough.  This result is a host of neurological problems, including seizures, for which doctors have no effective treatment.  A new study shows that an existing blood pressure drug may be able to prevent the molecular chain reaction in the brain triggered by ammonia. 

11/20/2013 | 1 comment

Arthur Moss Receives Honorary Degree from Hungarian University

On November 15th, Cardiology Professor Arthur J. Moss, M.D. received a Doctor Honoris Causa (honorary Ph.D. doctoral degree) from Semmelweis University in Budapest, Hungary for his many discoveries in the treatment and prevention of heart disease. 

11/18/2013 | 1 comment

Study Links Menstrual Cycle, Concussion Outcomes in Women

Researchers found that women injured during the two weeks leading up to their period (the premenstrual phase) had a slower recovery and poorer health one month after injury compared to women injured during the two weeks directly after their period or women taking birth control pills.

11/13/2013 | 1 comment

U.S. Health Care: Are We Getting the Best Bang for Our Buck?

A new study out today in the journal JAMA revisits the topic of whether or not the U.S. health care system – which now accounts for almost one-fifth of the nation’s economy – is delivering the best value in terms of health outcomes.  The paper also overturns several widely held beliefs about the factors responsible for growth in health care spending.

11/12/2013 | 2 comments

Bird Flu is Back in China: URMC Testing Vaccine Candidate

Two new cases of H7N9 bird flu were reported in China in October. With funding from the National Institutes of Health, the University’s Vaccine Research Unit is testing a new vaccine candidate in case H7N9 makes its way to the U.S. 

10/31/2013 | 1 comment

About The Blog

The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.

Follow @URMCResearch


Blog posts